1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Periodontal Disease - Pipeline Review, H2 2013

Periodontal Disease - Pipeline Review, H2 2013

  • August 2013
  • -
  • Global Markets Direct
  • -
  • 50 pages

Periodontal Disease - Pipeline Review, H2 2013

Summary

Global Markets Direct’s, 'Periodontal Disease - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Periodontal Disease, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Periodontal Disease. Periodontal Disease - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for Periodontal Disease.
- A review of the Periodontal Disease products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Periodontal Disease pipeline on the basis of route of administration and molecule type.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.

Reasons to buy

- Identify and understand important and diverse types of therapeutics under development for Periodontal Disease.
- Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
- Plan mergers and acquisitions effectively by identifying players of the most promising pipeline.
- Devise corrective measures for pipeline projects by understanding Periodontal Disease pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Table Of Contents

Periodontal Disease - Pipeline Review, H2 2013
Table of Contents

Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Global Markets Direct Report Coverage 6
Periodontal Disease Overview 7
Therapeutics Development 8
An Overview of Pipeline Products for Periodontal Disease 8
Periodontal Disease Therapeutics under Development by Companies 10
Periodontal Disease Therapeutics under Investigation by Universities/Institutes 12
Late Stage Products 13
Comparative Analysis 13
Mid Clinical Stage Products 14
Comparative Analysis 14
Early Clinical Stage Products 15
Comparative Analysis 15
Discovery and Pre-Clinical Stage Products 16
Comparative Analysis 16
Periodontal Disease Therapeutics - Products under Development by Companies 17
Periodontal Disease Therapeutics - Products under Investigation by Universities/Institutes 18
Companies Involved in Periodontal Disease Therapeutics Development 19
Aphios Corporation 19
Kaken Pharmaceutical Co.,Ltd. 20
CSL Limited 21
Yuhan Corporation 22
NeoStem, Inc. 23
Onepharm Research and Development GmbH 24
Canopus BioPharma Incorporated 25
Ensoltek Co., Ltd. 26
Biomedical Development Corporation. 27
Periodontal Disease - Therapeutics Assessment 28
Assessment by Monotherapy Products 28
Assessment by Route of Administration 29
Assessment by Molecule Type 31
Drug Profiles 33
POD CRC-OHS - Drug Profile 33
Product Description 33
Mechanism of Action 33
RandD Progress 33
trafermin - Drug Profile 34
Product Description 34
Mechanism of Action 34
RandD Progress 34
Iocide - Drug Profile 36
Product Description 36
Mechanism of Action 36
RandD Progress 36
Iocide - Drug Profile 37
Product Description 37
Mechanism of Action 37
RandD Progress 37
Asterias - Drug Profile 38
Product Description 38
Mechanism of Action 38
RandD Progress 38
YHD-14642 - Drug Profile 39
Product Description 39
Mechanism of Action 39
RandD Progress 39
Stem cell Therapy For Osteoporosis And Bone Regeneration - Drug Profile 40
Product Description 40
Mechanism of Action 40
RandD Progress 40
C5a Receptor Antagonist - Drug Profile 41
Product Description 41
Mechanism of Action 41
RandD Progress 41
IPS-02001 - Drug Profile 42
Product Description 42
Mechanism of Action 42
RandD Progress 42
Sharon-3000 - Drug Profile 43
Product Description 43
Mechanism of Action 43
RandD Progress 43
OPM-3023 - Drug Profile 44
Product Description 44
Mechanism of Action 44
RandD Progress 44
Periodontal Disease Therapeutics - Drug Profile Updates 45
Periodontal Disease Therapeutics - Dormant Products 46
Periodontal Disease - Product Development Milestones 47
Featured News and Press Releases 47
Nov 20, 2012: NeoStem Receives Notification Of $1.2m NIH Grant Award For First Clinical Study Of VSEL Technology In Humans 47
Mar 30, 2012: Kaken Pharma To Initiate Additional Phase III Trial For KCB-1D 47
Oct 21, 2004: Kaken Pharmaceutical Announces Results Of Early Phase II Clinical Trial On KCB-1D 48
May 29, 2002: BioMimetic Pharmaceuticals Initiates Pivotal Clinical Study with Platelet-derived Growth Factor for the Treatment of Periodontal Diseases 48
Appendix 49
Methodology 49
Coverage 49
Secondary Research 49
Primary Research 49
Expert Panel Validation 49
Contact Us 50
Disclaimer 50



List of Tables

Number of Products Under Development for Periodontal Disease, H2 2013 8
Products under Development for Periodontal Disease - Comparative Analysis, H2 2013 9
Number of Products under Development by Companies, H2 2013 11
Number of Products under Investigation by Universities/Institutes, H2 2013 12
Comparative Analysis by Late Stage Development, H2 2013 13
Comparative Analysis by Mid Clinical Stage Development, H2 2013 14
Comparative Analysis by Early Clinical Stage Development, H2 2013 15
Comparative Analysis by Discovery and Pre-Clinical Stage Development, H2 2013 16
Products under Development by Companies, H2 2013 17
Products under Investigation by Universities/Institutes, H2 2013 18
Aphios Corporation, H2 2013 19
Kaken Pharmaceutical Co.,Ltd., H2 2013 20
CSL Limited, H2 2013 21
Yuhan Corporation, H2 2013 22
NeoStem, Inc., H2 2013 23
Onepharm Research and Development GmbH, H2 2013 24
Canopus BioPharma Incorporated, H2 2013 25
Ensoltek Co., Ltd., H2 2013 26
Biomedical Development Corporation., H2 2013 27
Assessment by Monotherapy Products, H2 2013 28
Assessment by Stage and Route of Administration, H2 2013 30
Assessment by Stage and Molecule Type, H2 2013 32
Periodontal Disease Therapeutics - Drug Profile Updates 45
Periodontal Disease Therapeutics - Dormant Products 46



List of Figures

Number of Products under Development for Periodontal Disease, H2 2013 8
Products under Development for Periodontal Disease - Comparative Analysis, H2 2013 9
Products under Development by Companies, H2 2013 10
Products under Investigation by Universities/Institutes, H2 2013 12
Late Stage Products, H2 2013 13
Mid Clinical Stage Products, H2 2013 14
Early Clinical Stage Products, H2 2013 15
Discovery and Pre-Clinical Stage Products, H2 2013 16
Assessment by Monotherapy Products, H2 2013 28
Assessment by Route of Administration, H2 2013 29
Assessment by Stage and Route of Administration, H2 2013 30
Assessment by Molecule Type, H2 2013 31
Assessment by Stage and Molecule Type, H2 2013 32



Companies Mentioned

Aphios Corporation
Kaken Pharmaceutical Co.,Ltd.
CSL Limited
Yuhan Corporation
NeoStem, Inc.
Onepharm Research and Development GmbH
Canopus BioPharma Incorporated
Ensoltek Co., Ltd.
Biomedical Development Corporation.

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Periodontal Disease-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Periodontal Disease-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

  • $ 2000
  • Industry report
  • November 2016
  • by Delve Insight

DelveInsight’s Report, “Periodontal Disease-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III ...

Gingivitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Gingivitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

  • $ 2000
  • Industry report
  • November 2016
  • by Delve Insight

DelveInsight’s Report, “Gingivitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline ...

Global Animal Health Partnering Terms and Agreements 2010 to 2016

Global Animal Health Partnering Terms and Agreements 2010 to 2016

  • $ 1995
  • Industry report
  • October 2016
  • by Currentpartnering

Welcome to the Global Animal Health Partnering Terms and Agreements 2010 to 2016 report. The report provides a detailed understanding and analysis of how and why companies enter Animal Health partnering ...


Download Unlimited Documents from Trusted Public Sources

Infectious Disease Statistics in Denmark and Europe

  • November 2016
    65 pages
  • Infectious Dise...  

    Meat  

    Food  

  • Denmark  

    Europe  

View report >

Infectious Disease Statistics in the US

  • November 2016
    81 pages
  • Infectious Dise...  

    Anti-Infective  

  • United States  

View report >

Infectious Disease Statistics in France

  • November 2016
    10 pages
  • Infectious Dise...  

  • France  

View report >

Related Market Segments :

Mouth Disease

ref:plp2013

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.